160 results about "Acinetobacter" patented technology

The invention discloses an antibacterial peptide and application thereof, and belongs to the technical field of biology. The antibacterial peptide with an inhibition effect on various clinically common pathogenic microorganisms is obtained, and the antibacterial peptide comprises gram-negative bacteria such as escherichia coli, klebsiella pneumoniae, pseudomonas aeruginosa, acinetobacter baumannii, vibrio parahaemolyticus, salmonella gallinarum, salmonella typhimurium and enterobacter sakazakii, and gram-positive bacteria. The antibacterial peptide provided by the invention can be used as an antibacterial peptide, such as staphylococcus aureus, listeria monocytogenes and bacillus cereus, and the antibacterial peptide provided by the invention is novel in structure and easy to prepare.

The invention belongs to the technical field of antibacterial peptides, and particularly relates to an LL-37 derived antibacterial peptide and application thereof. According to the invention, 17-29aa of the LL-37 antibacterial peptide is used as a core fragment and is connected with an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO: 2 through an amido bond, the antibacterial activity of the obtained antibacterial peptide is obviously higher than that of the LL-37 antibacterial peptide, and the antibacterial peptide shows an obvious bactericidal effect on clinical drug-resistant bacteria such as acinetobacter baumannii, pseudomonas aeruginosa, escherichia coli, staphylococcus aureus, klebsiella pneumoniae and the like; meanwhile, the cytotoxicity and hemolytic activity are weak, drug resistance is not prone to being generated, bacteria can be rapidly killed in vivo through multiple mechanisms, no obvious cytotoxicity exists, the bacterium load in tissue is remarkably reduced, and the lifetime of a bacterium-infected mouse is prolonged.

The invention discloses a microbial composite flora, a microbial agent and application of the microbial composite flora and the microbial agent, and relates to the technical field of microorganisms and application of the microorganisms. The invention relates to a microbial composite flora, which is characterized in that the microbial composite flora comprises Acinetobacter sichuanensis LHH12, Pseudomonas sichuanensis SJ2-76, beneficial nitroreductase (Diaphorobacter nitroreducens SYY4, and Thauera ammoniaca SJ2-12, and the microbial composite flora comprises Acinetobacter sichuanensis LHH12, Pseudomonas sichuanensis SJ2-76, beneficial nitroreductase (Diaphorobacter nitroreducens SYY4, and Thauera ammoniaca SJ2-12. The microorganisms for constructing the composite flora are separated from the semi-coke wastewater, have better phenol resistance and chemical oxygen demand (COD) degradation capacity, and can be used for purifying high-phenol wastewater, biologically removing nitrogen and phosphorus and degrading COD. Under the condition that the original microbial community composition in the wastewater is not changed, the microbial compound flora can effectively improve the degradation rate of COD (Chemical Oxygen Demand) in the phenol-ammonia wastewater and effectively reduce the treatment cost of high-phenol-ammonia wastewater such as semi-coke and the like through the synergistic effect of the strains, and has great potential in the aspect of promoting the low-carbon green sustainable development of the coal chemical industry.

The invention discloses a phycomycete composite biological fertilizer for an arid loess area as well as a preparation method and application of the phycomycete composite biological fertilizer, and belongs to the technical field of biological fertilizers. The phycomycete composite biological fertilizer is prepared from nitrogen-fixing anabaena and acinetobacter, counted by a single cell, the total viable count of the anabaena azotica is greater than or equal to 1.0 * 10 < 6 > CFU / mL, and the total viable count of the acinetobacter is greater than or equal to 1.0 * 10 < 7 > CFU / mL. Experiments prove that the phycomycete composite biological fertilizer can significantly improve the germination potential and germination rate of crop seeds, promote seedling growth, improve the nutritional quality of crops and reduce the death rate of seedlings, is suitable for various crops such as wheat, Shanghai Qing and peas, and has important application value in agricultural production in arid regions.

The invention provides acinetobacter for culturing prawns in saline-alkali water and application of the acinetobacter. The preservation number of the provided acinetobacter is CGMCC (China General Microbiological Culture Collection Center) No.36066. The acinetobacter soilis strain provided by the invention has remarkable comprehensive application advantages, can still keep higher growth activity and metabolic capability in a low-temperature environment, and continuously plays a water body purification function. Ammonia nitrogen and nitrite nitrogen in a water body can be efficiently degraded, the environment of the aquatic water body is remarkably improved by promoting the nitrogen circulation process, and harm caused by nitrogen pollution is reduced. In addition, the strain can effectively inhibit and prevent reproduction of pathogenic vibrios and reduce the occurrence risk of bacterial diseases of aquatic animals. The strain is high in safety, does not cause poison or stress reaction to bred animals even under the condition of high-concentration use, and has good ecological safety and environmental friendliness.

The present invention relates to the pharmaceutical field, and provides a boric acid β-lactamase inhibitor or a use thereof. The boric acid β-lactamase inhibitor is a compound shown in formula (I), or an optical isomer or a pharmaceutically acceptable salt thereof: formula (I). The ultra-broad-spectrum boric acid β-lactamase inhibitor of the present invention has an inhibition effect on A, B, C, and D enzymes, and carbapenem drug-resistant bacteria such as Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, Acinetobacter baumannii, and Pseudomonas aeruginosa.

This invention relates to a 1,3,4-thiadiazole peptide deformylase inhibitor and its preparation and application. The structural formula is shown in formula (1): wherein, R 1 It is n-butyl or cyclopentylmethyl; R 2 The compounds are hydrogen-containing, straight-chain alkanes, cyclic alkanes, aromatic rings, substituted biphenyls, or heterocyclic rings. The 1,3,4-thiadiazole peptide deformylase inhibitors provided by this invention can effectively inhibit bacterial protein synthesis, thereby achieving sterilization. These compounds exhibit excellent inhibitory activity against Gram-positive drug-resistant bacteria, especially the clinically challenging methicillin-resistant Staphylococcus aureus (MRSA). In particular, some preferred compounds show inhibitory activity 4-8 times that of the control standards vancomycin and linezolid. The 1,3,4-thiadiazole peptide deformylase inhibitors provided by this invention also exhibit inhibitory activity against Gram-negative drug-resistant bacteria, especially against drug-resistant Acinetobacter baumannii, known as "superbugs," with an inhibitory activity reaching 0.5 μg / mL, far superior to vancomycin and linezolid.

The application discloses a malt PYF prediction method based on metagenome detection and belongs to the field of malt quality detection. Candida The relative abundance of Phytobacter The relative abundance of Curtobacterium The relative abundance of Kosakonia The relative abundance of Enterobacter The relative abundance of Fusarium The relative abundance of Aureobasidium The relative abundance of Acinetobacter The relative abundance of Klebsiella The relative abundance of The PYF potential is calculated, and the smaller the PYF potential is, the lower the degree of yeast pre-flocculation caused by the malt is. The application is applied to the yeast pre-flocculation degree prediction aspect, solves the problem that the existing malt PYF detection method cannot accurately reflect the yeast pre-flocculation condition in actual application, has the characteristics that the detection result is more accurate and can truly reflect the degree of yeast pre-flocculation caused by the malt.

The invention belongs to the technical field of medicines, and particularly relates to an aryl dicarboxylic acid compound, a preparation method and application of the aryl dicarboxylic acid compound as an antibacterial agent. The compound is shown as a formula (1), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are independently selected from hydrogen and halogen. Two ends of the molecule are connected through an N-phenylpropanamide connecting arm, the molecule is a compound with a novel structure, and the series of compounds have a relatively strong inhibition effect on acinetobacter baumannii and are worthy of further research and development.

The invention relates to the technical field of bacteriophages, and particularly discloses an acinetobacter baumannii bacteriophage, depolymerases and a preparation method and application of the acinetobacter baumannii bacteriophage. The acinetobacter baumannii bacteriophage P919 provided by the invention has very strong specific lysis capability on KL3 type acinetobacter baumannii, and the coded depolymerases of the acinetobacter baumannii bacteriophage P919 have excellent temperature stability at 70 DEG C or below, and can effectively degrade capsular polysaccharide of the KL3 type acinetobacter baumannii.

The invention relates to a biomarker for individual recognition and application thereof, and relates to the technical field of biology. The biomarker comprises at least one of the following microorganisms: propionibacterium acnes, staphylococcus epidermidis, marine paracoccus, streptococcus, rhodococcus fence celebrating, staphylococcus, pseudomonas, streptococcus sanguineus, achromobacter xylosoxidans, acinetobacter calcoaceticus, acinetobacter johnsonii, staphylococcus lentus, pseudomonas toralaris and brevundimonas vesicularis. Or enterococcus faecium. The biomarker can provide analysis with higher resolution in the aspect of differential strain information, has a better distinguishing effect, higher accuracy and sensitivity on individual recognition, and can be used as a new technical means for supplementing forensic individual recognition.

The present invention relates to an antibacterial or antifungal composition and a pharmaceutical composition for preventing or treating bacterial or fungal infections, both comprising VLX600. The antibacterial composition comprising VLX600 according to one aspect of the present invention exhibits antibacterial or antifungal activity against a wide range of strains, including Mycobacterium spp., Escherichia spp., Pseudomonas spp., Staphylococcus spp., Acinetobacter spp., Candida spp., and the like. The pharmaceutical composition comprising VLX600 demonstrates excellent antibacterial, antifungal, and therapeutic efficacy against pathogens and can be effectively utilized for the prevention or treatment of bacterial or fungal infections. Furthermore, VLX600 exhibits a synergistic effect with conventional antibiotics and thus is effective in treating infections caused by antibiotic-resistant bacterial strains.

The invention discloses a composite microbial agent for degrading micro-plastics in seawater and a preparation method thereof, the microbial agent is composed of effective viable bacteria and auxiliary components, the effective viable bacteria are marine-derived halomonas, acinetobacter and bacillus and pseudomonas with high affinity with the micro-plastics, the effective viable bacteria are compounded according to a specific viable bacteria number ratio, and the microplastics are degraded by the auxiliary components. And function collaboration is realized. The auxiliary components comprise a protective agent consisting of trehalose, skimmed milk, glycerol and cane sugar, and a nutritional agent consisting of glucose and yeast extract. The preparation method comprises the following steps: respectively fermenting, centrifugally concentrating, compounding in proportion, mixing with auxiliary components, and finally drying to prepare powder. The invention further discloses application of the microbial inoculum to degradation of microplastics in beach intertidal zones and ship wastewater systems. The microbial agent is high in pertinence, good in stability in a high-salt seawater environment and high in degradation efficiency, and an effective solution is provided for in-situ bioremediation of marine micro-plastic pollution.

The invention discloses a strain of lactobacillus muricatum and application thereof.The lactobacillus muricatum SZH025 obtained through the method has an obvious inhibiting effect on acinetobacter baumannii, klebsiella pneumoniae and escherichia coli under the in-vitro condition and is suitable for preventing and treating intestinal infectious diseases or adjusting intestinal flora; the cholate hydrolase (BSH) activity is remarkable, bile acid metabolism is facilitated, cholesterol excretion is promoted, and the blood fat reducing and regulating effects are achieved. In addition, the strain shows good safety characteristics, has relatively strong gastrointestinal tract environmental adaptability, has certain antioxidant function and ethanol decomposition capacity, is beneficial to alcohol metabolism, can produce oleic acid, and has potential probiotic effects of regulating lipid, resisting inflammation and improving the metabolic state of a host.

A strain Y26 for degrading lignin, characterized in that the strain Y26 is Acinetobacter baumannii (ATCC 19606T) Acinetobacter baumannii ), preserved in the China Center for Type Culture Collection, located at No. 299, Bajiyuan Road, Wuchang District, Wuhan City, Hubei Province, China, with a preservation number of CCTCCM20242944 and a preservation date of December 30, 2024. The Acinetobacter baumannii Y26 in the present application has excellent ability to degrade lignocellulose, with a Lac enzyme activity of 60.38±2.5 U / L, a Mnp enzyme activity of 2612.14±25 U / L, a Lip enzyme activity of 1460.62±14 U / L, and a lignin degradation rate in corn stalks of 38.93%. In the present application, the corn stalks are pretreated by using the Acinetobacter baumannii Y26 in combination with maleic acid, so that the cellulose conversion rate of the corn stalks reaches 87.41%, the glucose yield reaches 0.668 g / g of stalks, and the prepared saccharification liquid has small inhibition effect on microbial fermentation, effectively improving the ethanol yield.

The present invention relates to a composition that is used to primarily disrupt and remove biofilm from surfaces. This is achieved using a composition comprising a bacteriophage capable of lysing bacteria selected from one or more of Pseudomonas aeruginosa, Acinetobacter baumanii, Staphylococcus aureus, and E.coli; and a Bacillus bacterial spore in the presence of a specific surfactant of the poloxamer type.

The invention discloses a low-temperature denitrification strain and application of the low-temperature denitrification strain. The strain is Acinetobacter Bragg FX1, and the preservation number of the strain is CGMCC (China General Microbiological Culture Collection Center) NO: 36583. The strain can efficiently remove ammonia nitrogen, nitrate nitrogen and nitrite nitrogen in water at the temperature of 5-30 DEG C, especially shows the optimal denitrification performance at the temperature of about 10 DEG C, and the removal rate of the ammonia nitrogen and the nitrite nitrogen can reach 99% or above. The strain has strong adaptability to low-temperature environment, can tolerate water quality fluctuation of actual sewage, and solves the problems of low denitrification efficiency and unstable operation caused by insufficient microbial activity of sewage treatment plants in low-temperature regions. The strain can be used for preparing a low-temperature sewage denitrification microbial agent, can be directly added into a low-temperature domestic sewage or industrial wastewater treatment system, does not need to depend on high-energy-consumption heating and heat preservation measures, and has remarkable energy-saving and consumption-reducing potential, good environmental adaptability and wide application prospects.

The present invention belongs to the field of pharmaceutical technology and relates to a preparation that binds to the AbaR protein of Acinetobacter baumannii and its application. The present invention utilizes sansinol O to effectively bind to the AbaR protein in Acinetobacter baumannii, thereby inhibiting its AHL quorum sensing system. It has been confirmed that sansinol O can significantly inhibit the biofilm formation ability of Acinetobacter baumannii ATCC 19606 strain, reduce bacterial motility, and reduce bacterial toxicity to cells, without significantly affecting bacterial growth and causing selective pressure to promote bacterial evolution of drug resistance.

The invention relates to the technical field of biological detection, in particular to a nucleic acid combination product, a PCR premix, a method and a kit for identifying respiratory tract pathogenic bacteria. The nucleic acid combination product comprises a primer pair as shown in SEQ ID NO: 1 to SEQ ID NO: 21 and a probe. The invention provides a nucleic acid detection product for detecting klebsiella pneumoniae, streptococcus pneumoniae, haemophilus influenzae, pseudomonas aeruginosa, acinetobacter baumannii, staphylococcus aureus and moraxella catarrhalis, and the nucleic acid detection product can be used for performing amplification detection on conserved fragments of target pathogens in the same PCR reaction system, and is efficient and low in cost. Moreover, the anti-interference capability is strong, and the sensitivity is high.

The application discloses a chimeric endolysin Lys009-Lys009CBD and engineering and application thereof, and belongs to the field of genetic engineering and protein engineering. The application constructs a chimeric endolysin Lys009-Lys009CBD with high activity, and the peptidoglycan hydrolysis activity of the chimeric endolysin Lys009-Lys009CBD on Pseudomonas aeruginosa is 5.30 times that of natural endolysin Lys009 and 27.98 times that of hen egg white lysozyme HEWL. A transmembrane peptide P81417 is further fused to perform transmembrane modification, and an engineering endolysin P81417-Lys009-Lys009CBD is obtained. The engineering endolysin can efficiently lyse Pseudomonas aeruginosa, Acinetobacter baumannii and the like, and has excellent thermal stability. The application enriches the resource library of high-activity endolysins, provides important experimental basis and technical support for developing an anti-drug-resistant bacteria treatment strategy, and also provides a new selection for clinical treatment of multiple drug-resistant bacteria infection.

The application discloses application of combined inoculation of rhizosphere phosphorus solubilizing bacteria in plant growth promotion and soil nutrient improvement, and belongs to the technical field of microorganisms.The combined inoculation of acinetobacter and pantoea provided by the application can effectively convert insoluble inorganic phosphorus into soluble inorganic phosphorus, and promotes the utilization of phosphorus.The combined inoculation of acinetobacter and pantoea has significant soil phosphorus solubilizing capacity and plant growth promotion effect when the ratio of acinetobacter to pantoea is (4-6):(6-4), and can be applied to improving soil phosphorus utilization rate and promoting plant growth, and has important agricultural and environmental values.

The invention discloses application of chlorpromazine hydrochloride in preparation of an acinetobacter baumannii infection resisting medicine, and belongs to the technical field of biological medicine. The invention proves that when the chlorpromazine hydrochloride is independently used, the growth of the acinetobacter baumannii can be inhibited, wherein the acinetobacter baumannii comprises colistin-resistant acinetobacter baumannii; meanwhile, chlorpromazine hydrochloride can cooperate with colistin to play a role in resisting acinetobacter baumannii, so that infection caused by colistin-resistant acinetobacter baumannii is treated. When a certain concentration of chlorpromazine hydrochloride and colistin are combined for use, more than 50% of colistin-resistant acinetobacter baumannii is killed within 4 hours, and the survival rate is lower than 1%, which proves that chlorpromazine hydrochloride and colistin have a synergistic effect. The chlorpromazine hydrochloride and the colistin are combined for use, so that the chlorpromazine hydrochloride and the colistin can be used for resisting colistin drug-resistant pathogens and treating diseases caused by colistin drug-resistant bacteria infection, and meanwhile, the evolution of colistin drug resistance can also be prevented.

The application discloses a strain of Acinetobacter, the strain name is C16ZT1, and simultaneously proposes a bacterial agent containing the different bacillus, and further uses the bacterial agent for treating petroleum pollution wastewater. The Acinetobacter can efficiently degrade the petroleum production wastewater containing chain alkanes, can still realize the degradation effect quickly and stably under the conditions of high concentration, high salt and extreme acid and alkali, and can degrade more than 95% of the petroleum production wastewater within 144 hours. In the application in sewage treatment, the strain has strong tolerance, can tolerate high-concentration alkanes, and has a wide adaptation range to salt concentration, pH and the like, and has a good application prospect.

The application belongs to the technical field of medicine, and discloses application of pyruvic acid in preparation of a preparation for improving sensitivity of pathogenic bacteria to antibiotics. Researches of the application show that pyruvic acid can significantly improve the sensitivity of pathogenic bacteria to antibiotics, and pyruvic acid combined with antibiotics can be used to prepare a medicine for treating pathogenic bacterial infection. The medicine has good antibacterial, anti-drug-resistant bacterial and anti-infection effects on pathogenic bacteria such as pseudomonas aeruginosa, acinetobacter baumannii and parahemolytic vibrio, especially drug-resistant bacteria. The medicine has good application value and significance in the production and development of antibacterial drugs and anti-infection drugs in combination with antibiotics.

This invention relates to the fields of environmental microbiology and wastewater treatment technology, specifically to a highly salt-tolerant Acinetobacter baumannii strain for heterotrophic nitrification and aerobic denitrification of wastewater, a microbial agent, and its application. The strain is Acinetobacter baumannii. Acinetobacter baumannii M4, deposited on May 12, 2025, at the Guangdong Provincial Microbial Culture Collection Center, located at 5th Floor, Building 59, No. 100 Xianlie Middle Road, Yuexiu District, Guangzhou, Guangdong Province, with accession number GDMCC No: 66302. This invention utilizes the *Acinetobacter baumannii* strain M4, domesticated using a multi-round salt-beating method. It can grow in high-salt-alkali environments and exhibits both heterotrophic nitrification and aerobic denitrification capabilities. It can be widely applied to the biological denitrification and phosphorus removal treatment of high-salt-alkali nitrogen and phosphorus wastewater, including wastewater from aquaculture, pickling, and industrial processes.

The invention belongs to the field of microorganisms, and discloses an ammonia nitrogen conversion strain and application thereof, a strain D-5 with an ammonia nitrogen conversion effect provided by the invention is Acinetobacter seohaensis, and the strain D-5 can directly convert ammonia nitrogen into hydroxylamine, nitrite and nitrate. The strain is cultured in swine wastewater (liquid part after solid-liquid separation) with high-concentration nitrogen, phosphorus and organic carbon, the growth condition of the strain is good, the ammonia nitrogen conversion effect is remarkable, and the ammonia nitrogen conversion rate reaches 86.92%.

The invention belongs to the technical field of bioengineering, and particularly relates to a phage cocktail and application thereof. The bacteriophage cocktail comprises five bacteriophages PGPA20, PGPA60, PAB26, Lkpp-25 and Lkpp-36 which are separated from the natural world, and the bacteriophage cocktail has relatively strong bactericidal activity on pseudomonas aeruginosa, acinetobacter baumannii and K1 / K2 type klebsiella pneumoniae, and has specificity on the pseudomonas aeruginosa, the acinetobacter baumannii and the K1 / K2 type klebsiella pneumoniae; the bacteriophage can be compounded with other substances for use, and a safe and non-toxic bacteriophage killing product is provided for in-vivo and in-vitro infection treatment of pseudomonas aeruginosa, acinetobacter baumannii and K1 / K2 type klebsiella pneumoniae and disinfection and purification of pseudomonas aeruginosa, acinetobacter baumannii and K1 / K2 type klebsiella pneumoniae in the breeding industry and other environments.

The application discloses a liposome vaccine of Acinetobacter baumannii outer membrane protein and a preparation method and application thereof, and relates to the field of biological medicines. The application efficiently expresses the Acinetobacter baumannii outer membrane protein through a genetic engineering method, and obtains a liposome vaccine of Acinetobacter baumannii outer membrane protein by combining the obtained various outer membrane proteins as antigens with a lipid mixture and an adjuvant. It is verified that the vaccine can provide complete protection for mice attacked by a lethal dose of Acinetobacter baumannii. In the application, the outer membrane protein loaded in the liposome is re-folded in structure, the immunogenicity of the protein is enhanced, and the liposome can reduce the toxicity of the outer membrane protein. Omp38+BauA+FimA can be an effective antigen combination for preventing Acinetobacter baumannii infection. Pam2CSK4 as a TLR2 agonist has a strong auxiliary effect on the liposome vaccine of Acinetobacter baumannii, and can induce the activation of an innate immune response, thereby providing more comprehensive protection for a host.

The application relates to the technical field of biological medicine, and particularly discloses application of indole-3-methanol in preparation of polymyxin antibacterial synergist and a gram-negative bacterium-resistant pharmaceutical composition, the application of the indole-3-methanol in preparation of the polymyxin antibacterial synergist, the concentration of the polymyxin and the indole-3-methanol is 0.01-2 (mu g / mL):0.01-10 mM; the gram-negative bacterium-resistant pharmaceutical composition comprises the polymyxin and the indole-3-methanol, and further comprises pharmaceutically acceptable adjuvants and / or carriers; the composition can be prepared into injections, ointments or aerosols, and can be used for treating klebsiella pneumoniae, bauman acinetobacter, escherichia coli or pseudomonas aeruginosa and the like; the application discloses that the indole-3-methanol can synergize with the polymyxin, significantly improves the bactericidal activity of the polymyxin on gram-negative bacteria, reduces the use dosage of the polymyxin, improves the antibacterial efficacy, prolongs the antibacterial time, and delays the generation of drug resistance.

The application discloses a kind of microbial complex bacterial population, microbial inoculum and application thereof, and is related to microorganism and application technical field.The microbial complex bacterial population includes Acinetobacter sichuanensis LHH12, Pseudomonas songnenensis SJ2-76, Diaphorobacter nitroreducens SYY4 and Thauera aminoaromatica SJ2-12.The microorganism for constructing complex bacterial population is obtained from semi-coke wastewater, and has good phenol tolerance and chemical oxygen demand (COD) degradation capacity, and can be used for purifying high-phenol wastewater, biological denitrification and phosphorus removal and degrading COD.The microbial complex bacterial population of the application can effectively improve the COD degradation rate in phenol ammonia wastewater and effectively reduce the treatment cost of high-phenol ammonia wastewater such as semi-coke without changing the original microbial community composition of wastewater through the synergistic effect between strains, which has great potential for promoting low-carbon green and sustainable development of coal chemical industry.